Treatment and outcomes in diabetic breast cancer patients (Q38180008)

30 August 2017

0 references

Treatment and outcomes in diabetic breast cancer patients (English)

1 reference

30 August 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442643%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Joey Nicholson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442643%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Niyati Parekh

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442643%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Nour Makarem

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442643%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

English

0 references

publication date

18 January 2014

1 reference

Breast Cancer Research and Treatment

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442643%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442643%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442643%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

551-570

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442643%20AND%20SRC:MED&resulttype=core&format=json

Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Multimorbidity is associated with better quality of care among vulnerable elders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Role of age and health in treatment recommendations for older adults with breast cancer: the perspective of oncologists and primary care providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Metformin in breast cancer: time for action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

A prospective study of the associations between treated diabetes and cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

The impact of diabetes mellitus on breast cancer outcomes: a single center retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Medical comorbidities predict mortality in women with a history of early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Structural estimates of treatment effects on outcomes using retrospective data: an application to ductal carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Identifying risk factors for surgical site infections in mastectomy patients using the National Surgical Quality Improvement Program database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Obesity, adipocytokines, and insulin resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Adipose tissue, adipokines, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Growth factors can influence cell growth and survival through effects on glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Long-term metformin use is associated with decreased risk of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Is it time to test metformin in breast cancer clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Metformin and breast cancer risk: a meta-analysis and critical literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X

Obesity and cancer: Pathophysiological and biological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2833-X